chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Could not move the arm for a week/Could not move the arm/Can hardly function; Joint pain in hips, knees and ankles/Hips are the worst/Pain is incredible; vaccine "killed my arm," swelled up and could not move the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (vaccine "killed my arm," swelled up and could not move the arm), MOBILITY DECREASED (Could not move the arm for a week/Could not move the arm/Can hardly function) and ARTHRALGIA (Joint pain in hips, knees and ankles/Hips are the worst/Pain is incredible) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 088D21A and 066D21A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (vaccine "killed my arm," swelled up and could not move the arm), MOBILITY DECREASED (Could not move the arm for a week/Could not move the arm/Can hardly function) and ARTHRALGIA (Joint pain in hips, knees and ankles/Hips are the worst/Pain is incredible). At the time of the report, PAIN IN EXTREMITY (vaccine "killed my arm," swelled up and could not move the arm), MOBILITY DECREASED (Could not move the arm for a week/Could not move the arm/Can hardly function) and ARTHRALGIA (Joint pain in hips, knees and ankles/Hips are the worst/Pain is incredible) outcome was unknown.            No concomitant drug details were reported. No treatment details were reported.
N/A. Administration error.  Patient was administered on 1 dose that was sitting on room temperature more than 2 hours.
Fever (100.0), body aches, chills, cold sweats, headache, fatigue. Ibuprofen and tylenol for treatment.
Patient states that there was extreme pain at site of injection and down entire arm at time of vaccination. Patient also states that a loud, long severe crunch was heard at time of injection. Pharmacist is unaware of any such claims. States pain has been ongoing since time of injection and doctors have advised to use antiinflammatories and heat.
he had some soreness under both arms; some soreness under both arms and going to her breast; I am feeling a lot of discomfort under both arms; Painful and uncomfortable and sore as well as in her upper back; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID. The reporter is the patient.  A 66-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Lot number: GH9702) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine janssen (Caller states she had J&J last year), administration date: 2021, for COVID-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "he had some soreness under both arms"; BREAST PAIN (non-serious), outcome "unknown", described as "some soreness under both arms and going to her breast"; LIMB DISCOMFORT (non-serious), outcome "unknown", described as "I am feeling a lot of discomfort under both arms"; BACK PAIN (non-serious), outcome "unknown", described as "Painful and uncomfortable and sore as well as in her upper back".
every since the second morning after my vaccination my joints were extremely inflamed. I could barely walk, or use my arms. All of my joints are still aching. especially my knees and back. and hips, elbows. I went to my orthopedic doctor 6 weeks ago for injections for my knees they didn't help.  I'm walking so low My knees don't want to bend. I'm using a cane to walk what in the world could cause me so much pain.  I'm taking Tylenol extra strength 4 / 500 mil. at a time 4-5 hours apart, and they don't work.
Pt recv vax on 3/5/98; post vax pt exp nausea & vomiting
Seven days after the injection a lumpy rash appeared at the site of shot.  Skin was warm.  I do not consider this serious and did read information on this side effect.  I thought it was best to report for data collection.  I will get the second shot.
Arm soreness followed by chills, headache, body aches and low-grade fever. These symptoms lasted about a day and a half after the injection.
SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 2021, the patient experienced suspected covid-19 infection and suspected clinical vaccination failure. Patient wanted to thank for the 1 dose vaccine which helped her symptoms to be lesser.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the suspected covid-19 infection and suspected clinical vaccination failure was not reported. This report was associated with product quality complaint: 90000177503. This report was serious (Other Medically Important Condition).; Sender's Comments: V0;20210451340- covid-19 vaccine ad26.cov2.s -suspected vaccination failure. This event(s) is considered not related. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
c/o redness & swelling lt hip & leg, cried non stop x 4hrs;pt recvd APAP prior to shot & p/shot & 2x following;still had tender leg next day;denies any high fever;
Redness and pain at injection site.  Fever, chills, fatigue , muscle aches
About an hour and a half after the injection, I felt nausea, a headache, tiredness, and a genal feeling of not feeling well.  I ate some food and drank some ginger tea and it helped a little but after another hour I felt terrible with the same symptoms.  They lasted for three days where I needed to go to bed by 6:00 PM or as soon as I could each night.  On Sunday, January 24, 2021, 12 days after receiving the vaccine my eyes turned red and tired.  I took my Claritin that I take if my allergies bother me and did some eye drops but it did not go away.  I have had read eyes for five days now, it's more of a strained eye look and no other symptoms such as discharge, just a red eye on the whites of my eye.  I do not know if this is related to the vaccine, but my allergies meds are not working, eyedrops are not working, and I had a COVID Lab test Monday 1/25/21 it was negative and a COVID Rapid test today 1/28/21 and it was negative.
I had pain in my arm and it was swollen up. I was really tired. I had a headache (low grade), dizziness, and an hour or 2 later I started getting chills really bad. The next day I felt dizzy and kind of foggy. I did not take my temperature.
This is a spontaneous report from a contactable Certified Medical Assistant reporting on behalf of a physician. This Certified Medical Assistant reported similar events for six patients. This is the third of six reports. A 6-month-old male patient received, on 05Sep2017 at 15:00, the third dose of PREVNAR 13 (NDC number: 00035197102, lot S35325, Expiry Date 31Jul2018) intramuscularly, in the left thigh at single dose, for immunization. Relevant medical history was unknown. Concomitant medications included PEDIARIX (Lot. 924Y3, Expiration date: 11Aug2019) intramuscular route in the right thigh; HIB, Lot. N003701 via intramuscular route in the left thigh; and rotavirus vaccine (Lot. G4434, Expiration date: 22Oct2018) orally. The patient previously received the first dose of PREVNAR 13 on 05May2017 and the second dose on 14Jul2017. There was temperature excursion of PREVNAR 13 due to power outage with a maximum temperature of  8.5 degrees Celsius and maximum of 1 hour out of range on 03Sep2017 at 1:55 am. The patient received the vaccine after the temperature excursion. On an unspecified date, the patient experienced fever. Clinical outcome was unknown at time of this report. ; Sender's Comments: Linked Report(s) : US-PFIZER INC-2017396547 different patient, same product, same event.
Problems with vision in left eye within half hour of vaccine.  By Tuesday having difficulty reading, contacted eye Dr on 4/6/21 at 9.30.  Diagnosis of leak of the macular.  Will consult with Dr who is a Retinal Specialist who has been following me for the last year and half due to early stages of macular degeneration.  Saw Dr in January, 2021 and everything was fine.  Instructed to follow up in a year.  Would like Pfizer's advice  if this is could be a coincidence or could this macular leakage be due to vaccine and should I get the second shot on May 2nd.
Pt describes having tinnitus shortly after receiving her first covid vaccine. The tinnitus has continued.
Vaccines 6/28; started w/ urticaria 7/3; cluster of lesions to (R) thigh surrounding injection site; 10-15 other diffusely spread urticarial lesions to trunk, legs, jaw line - slight cough 1 day prior to rash; no other symptoms.
Chills, feverish feeling but no fever,  severe body aches, joint pain. Upper left arm hot to touch and extremely sore. Arm still sore next day and feeling achy and nauseated. Stayed home from work.
Involuntary twitching; pain in arm; High blood pressure; headache; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch Number: unknown), via unspecified route of administration in the left arm on 18Mar2021 at 07:00 PM (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not included. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. The patient was not tested positive for COVID-19 since the vaccination. On 18Mar2021 at 07:00 PM, the patient experienced twitching, pain in arm, blood pressure high and headache. The patient reported that involuntary twitching in her left arm since she received the vaccine 24 hours ago resulting in difficulty going to sleep, relaxing. Pain in arm resulting in difficulty raising her arm to lift, clean, dress. High blood pressure and headache lasted 24 hours. The Clinical outcomes of twitching, pain in arm and blood pressure high were not resolved; while that of headache was resolved.  No follow-up attempts are possible; information about lot number cannot be obtained.
The patient has experienced numerous respiratory infections since September of 2000 and was diagnosed with bronchial asthma as well. The patient developed eczema on her arms 1 week after immunization on 09/22/2000. On 10/06/2000 the patient developed a fever of 102F. On 10/07/2000 she experienced a cough progressing to "croupy non-stop worse at night". The patient experienced posterior headaches and was diagnosed with cervical pharyngitis and laryngitis. On 11/13/2000 the patient developed cervical adenitis and pharnygitis. On 11/14/2000 the patient developed a cold for three days. On 12/20/2000 the patient developed a runny nose, bronchial cough and bronchitis. On 01/11/2001 the patient experienced otitis media. On 02/27/2001 the patient experienced an upper respiratory infection and bronchitis. The patient was treated with Ventolin, amoxicillin, azithromycin, Zyrtec, and Zithromax. Subsequently, it was noted that the patient recovered from eczema, cough and asthma. Additional information is not expected.
I have eczema and use Dupixient; rash that is everywhere- big red blotches; rash that is everywhere- big red blotches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID:. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: ECZEMA (non-serious), outcome "unknown", described as "I have eczema and use Dupixient"; RASH (non-serious), ERYTHEMA (non-serious), outcome "unknown" and all described as "rash that is everywhere- big red blotches". Therapeutic measures were taken as a result of eczema, rash, erythema.  Additional information: Patient have eczema and used Dupixient. The vaccine and Dupixient shots worked through shots 1 and 2 but since the booster, not only isn't the Dupixient working but  has a different looking rash that is everywhere big red blotches. The patient asked to have heard of this before and how can it be treated and even topical cremes for eczema are not working.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
I spoke with client 9/3/03, client began experiencing heart palpitations without chest pain or shortness of breath, on august 30, 2003.  Palpitations continued intermittently through September 1, 2003.  Denies any of these symptoms today.  Client did not seek medical advice until referred to her family physician by the nurse at the health center. Client states she had a similar experience several years age;  after testing, symptoms were attributed to "stree" and no treatment prescribed.  Client has appointment for "echo-stress test", 9/4/03.  She will call me with results.  RN 9/3/03.
Within 30 minutes post vax the pt noticed her vision was blurry. She looked in a mirror and saw that her pupil was dilated (no iris seen). She was referred to an ophthalmologist who found nothing wrong other than the pupil was dilated. By evening, the pupil was getting smaller, it was back to normal and her vision was ok. The most recent information received, reports the condition of the pt is resolved.
Information has been received from a medical assistant concerning a female who on 28-OCT-2008 was vaccinated with PNEUMOVAX 23 (dose and route not reported). On 29-OCT-2008 the patient experienced wheezing and achiness. It was not known if this was the patient's first dose of PNEUMOVAX 23. The patient's wheezing and achiness persisted. Follow-up information has been received from a physician concerning a 50 year old female with anxiety, rhinitis allergic and menopause and a history of irritable bowel syndrome and no illness at the time of vaccination who on 27-OCT-2008 was vaccinated with PNEUMOVAX 23 (lot number: 660717/0224X) IM into her right upper arm. Concomitant therapy included FLUZONE and ADACEL. On 27-OCT-2008 the patient experienced wheezing, bodyaches, headache and sore throat. The patient was treated with naproxen, albuterol, QVAR, and an unspecified medication. Approximate 1 week later, the patient recovered. Additional information is not expected.
Bumpy, red, itchy rash head to toe started 8 PM. Plays and sleeps, but eats poorly. Rash less now on abdomen, still on extremities. Using Tylenol for fever, Benadryl for itch and rash.
5 minutes after the shot, pt started to complained of tightness in the throat and difficulty breathing, EpiPen was administer and 911 was called for the patient.  patient is now recovering in the hospital.  Doctor believes that effect is psychosomatic.
Headache Chills, right arm swelling, spine hurting, bottom of feet hurting Narrative:
Fever > 104 occurring estimate 3 hours after vaccines. Patient also had vomiting & diarrhea. Diarrhea did occur in a small amount x 1 prior to vaccinations.
This case was reported by a consumer via call center representative and described the occurrence of influenza in a 72-year-old male patient who received SHINGRIX for prophylaxis. On 14th July 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, several days after receiving SHINGRIX, the patient experienced influenza. On an unknown date, the outcome of the influenza was unknown. It was unknown if the reporter considered the influenza to be related to SHINGRIX. Additional details were reported as follows: The case was reported by the wife of the patient. The patient received the SHINGRIX vaccine and had the flu and not sure if he could get his 2nd dose of SHINGRIX vaccine. The reporter had granted permission for GlaxoSmithKline to contact patient's healthcare professional if needed.
He was not able to function so he stayed in bed; Extreme muscle discomfort in every muscle; Joint discomfort; Pain at the injection site the first 2-3 days; Muscle and joint pain; Muscle and joint pain; This is a spontaneous report from a contactable consumer (patient).   A 68-year-old male patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) on an unspecified date, at single dose, for immunization. Relevant medical history and concomitant medications were unknown. On an unspecified date, the patient experienced pain at the injection site the first 2-3 days, extreme muscle discomfort in every muscle, joint discomfort, muscle and joint pain and he was not able to function so he stayed in bed. The patient recovered from vaccination site pain; while clinical outcome of the other adverse events was unknown at time of this report.  The information on the lot number has been requested.
Initial report received on 6/19/06 from a healthcare professional. A 14 year old female patient with no significant medical history had received an IM dose of Adacel, lot number C2457AA, in the left upper arm and an IM dose of Menactra, lot number U2057AA, in the right upper arm on 6/6/06. Approximately five minutes post immunization, the patient lost consciousness and fell off the exam table onto the floor. The patient was unconscious for one minute, and was subsequently evaluated by the physician. No treatment was provided and no diagnostic testing, or laboratory data were performed. Reportedly, the patient did not have any illnesses at the time of the vaccinations. At the time of this report, the patient had recovered from these events. The reporter for this case is the same as for cases 200601529 and 200601530. (OMIC)
Intense burning and pain near injection site. Has taken APAP or ASA but as soon as wears off, pain returns. This is day 5.
72 hours after receiving the PFIZER COVID VACCINE #1, EB experienced very constant tinnitis. Patient reports it being deafening and constant. The tinnitis became lessened after a few days but patient can still hear it. Patient reported that it was still an issue 21 days after the first vaccination when he returned to the pharmacy for his second vaccine. Within the same day of administering PFIZER COVID VACCINE #2, patient reports tinnitis has returned at a deafening volume.
Itchy throat; Nose congestion; Clarifying caller is not sure if it's a cold or allergies; Clarifying caller is not sure if it's a cold or allergies; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A 23 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 09Mar2021 (Lot number: EN6203) at the age of 23 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing); "seasonal allergies" (unspecified if ongoing), notes: Allergy, She had allergies since she was a kid, but it is seasonal allergies,. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose 1, single, Lot: EL9266, she thinks she got it in the Left arm.), administration date: 16Feb2021, for Covid-19 immunization.  The following information was reported: THROAT IRRITATION (non-serious) with onset 10Oct2021, outcome "not recovered", described as "Itchy throat"; NASAL CONGESTION (non-serious) with onset 10Oct2021, outcome "not recovered", described as "Nose congestion"; HYPERSENSITIVITY (non-serious), NASOPHARYNGITIS (non-serious) all with onset Oct2021, outcome "not recovered" and all described as "Clarifying caller is not sure if it's a cold or allergies".  Additional Information: She had allergies since she was a kid, but it is seasonal allergies, it tends to happen any season of the year. Caller clarified that she is experiencing an itchy throat and a congested runny nose. Caller states that she hasn't taken her temperature at all but she does not feel like she is burning up. Caller states that she felt worse today morning, and is worse today than yesterday. She was schedule to get the booster today, however she woke up with what she thinks was a cold. She was actually not sure if its a cold since she was not running a fever but she had allergies also. Clarifying caller was not sure if it's a cold or allergies. Caller asks should she postpone getting the booster or was she okay to get it.  Follow-up attempts completed. No follow-up attempts are possible. No further information is expected.
diffuse erythematous rash, facial swelling. Onset within 1 hour of vaccine
No adverse event; Administered expired vaccine today; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine today) and NO ADVERSE EVENT (No adverse event) in a 25-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 047C22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 29-Mar-2023, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 29-Mar-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine today). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine today) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine today).    No concomitant medications were provided. Patient was administered with expired vaccine on 29-Mar-2023. No treatment medication was provided.